↓ Skip to main content

Dove Medical Press

Clinical Efficacy of the Chinese Herbal Medicine Shumian Capsule for Insomnia: A Randomized, Double-Blind, Placebo-Controlled Trial

Overview of attention for article published in Neuropsychiatric Disease and Treatment, March 2022
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (53rd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (53rd percentile)

Mentioned by

twitter
3 X users

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
17 Mendeley
Title
Clinical Efficacy of the Chinese Herbal Medicine Shumian Capsule for Insomnia: A Randomized, Double-Blind, Placebo-Controlled Trial
Published in
Neuropsychiatric Disease and Treatment, March 2022
DOI 10.2147/ndt.s349427
Pubmed ID
Authors

Suzhen Chen, Zhi Xu, Yinghui Li, Tianyu Wang, Yingying Yue, Zhenghua Hou, Linlin You, Na Lu, Yingying Yin, Xiaoyun Liu, Liangliang Tan, Houcheng Ji, Yaoran Shi, Xiaoyun Xin, Wenhao Jiang, Yonggui Yuan

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 17 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 17 100%

Demographic breakdown

Readers by professional status Count As %
Lecturer > Senior Lecturer 1 6%
Student > Bachelor 1 6%
Student > Ph. D. Student 1 6%
Student > Master 1 6%
Researcher 1 6%
Other 1 6%
Unknown 11 65%
Readers by discipline Count As %
Medicine and Dentistry 4 24%
Psychology 1 6%
Nursing and Health Professions 1 6%
Unknown 11 65%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 April 2022.
All research outputs
#14,925,951
of 25,392,582 outputs
Outputs from Neuropsychiatric Disease and Treatment
#1,360
of 3,131 outputs
Outputs of similar age
#203,081
of 449,877 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#13
of 32 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. This one is in the 40th percentile – i.e., 40% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,131 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one has gotten more attention than average, scoring higher than 55% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 449,877 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.
We're also able to compare this research output to 32 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.